KRAS and BRAF Mutation in Borderline Epithelial Type Ovarian Tumor
Objective: To understand the molecular profile by identifying the mutation of KRAS and BRAF in borderline type ovarian tumor. Method: In the study, we examined paraffin tissue sample from Department of Pathology Anatomy, University of Indonesia/Dr. Cipto Mangunkususmo Hospital, Jakarta, that was dia...
Saved in:
Main Author: | Dodi Suardi (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Society of Obstetrics and Gynecology,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRAF mutational analysis in ovarian tumors: recent perspectives
by: Wong KK, et al.
Published: (2015) -
P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
by: Sundov Dinka, et al.
Published: (2013) -
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
by: Abolfazl Yari, et al.
Published: (2020) -
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
by: Shen Shanxiang, et al.
Published: (2012) -
Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
by: Yan Xu, et al.
Published: (2017)